Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px

Product › Details

gene therapy

	Next higher product group	BIOTECH

Record changed: 2019-04-05

More documents for gene therapy

[1] Uniqure N.V.. (4/8/19). "Press Release: Uniqure Receives FDA Fast Track Designation for AMT-130 Gene Therapy for the Treatment of Huntington’s Disease". Lexington, MA & Amsterdam....
[2] Roche. (4/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Withdrawal and Refiling of Premerger Notification and Report Form under the HSR Act and Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel....
[3] Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy". Brisbane, CA & New York, NY....
[4] Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data". Brisbane, CA....
[5] Novartis AG. (4/1/19). "Press Release: AveXis Expands World-leading Gene Therapy Manufacturing Capacity with Purchase of Advanced Biologics Therapy Manufacturing Campus in Longmont, Colorado". Basel....
[6] Bluebird Bio, Inc.. (3/29/19). "Press Release: Bluebird Bio Receives Positive Opinion from CHMP for Zynteglo (autologous CD34+ cells encoding ßA-T87Q-globin gene) Gene Therapy". Cambridge, MA....
[7] Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London....
[8] MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY....
[9] Orchard Therapeutics Ltd.. (3/21/19). "Press Release: Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights". Boston, MA & London....
[10] Vivet Therapeutics S.A.S.. (3/20/19). "Press Release: Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics". Paris & New York, NY....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Advertise

gene therapy

More documents for gene therapy